Clinical trial
Cystic Fibrosis - Insulin Deficiency, Early Action
NCT01100892 · Sydney Children's Hospitals Network, Other · Completed
Key facts
| NCT number | NCT01100892 |
|---|---|
| Title | Cystic Fibrosis - Insulin Deficiency, Early Action |
| Official title | Cystic Fibrosis - Insulin Deficiency, Early Action |
| Acronym | CF-IDEA |
| Lead sponsor | Sydney Children's Hospitals Network, Other |
| Collaborators | John Hunter Children's Hospital Lady Cilento Children's Hospital, Brisbane Women's and Children's Hospital, Adelaide Children's Hospital Colorado |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis, Diabetes |
| Intervention type | Drug |
| Interventions | Once-daily insulin detemir |
| Enrollment | 100 |
| Start date | Dec 1, 2010 |
| Primary completion | Feb 1, 2023 |
| Completion | Feb 1, 2023 |
| First posted | Apr 9, 2010 |
| Last update posted | May 31, 2023 |
| Countries | Australia, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: